Log In
Print
BCIQ
Print
Print this Print this
 

JHL1921

  Manage Alerts
Collapse Summary General Information
Company JHL Biotech Inc.
DescriptionBiosimilar
Molecular Target
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today